Price
Financials
Standalone, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 23.15 | 18.08 | 28.89 | 31.66 | 32.23 | 22.99 | 28.13 | 18.82 | 19.03 | 21.56 | 26.48 | 29.62 |
| Operating costs | 17.00 | 15.98 | 22.64 | 20.92 | 25.72 | 16.67 | 25.44 | 16.64 | 14.09 | 19.67 | 20.28 | 24.13 |
| EBITDA | 6.15 | 2.10 | 6.25 | 10.74 | 6.51 | 6.32 | 2.69 | 2.18 | 4.94 | 1.89 | 6.20 | 5.49 |
| EBITDA margin % | 26.57% | 11.62% | 21.63% | 33.92% | 20.20% | 27.49% | 9.56% | 11.58% | 25.96% | 8.77% | 23.41% | 18.53% |
| Depreciation & amortisation | 0.44 | 0.49 | 0.50 | 0.49 | 0.51 | 0.50 | 0.51 | 0.45 | 0.45 | 0.69 | 0.54 | 0.66 |
| Finance costs | 0.00 | 0.00 | 0.00 | 0.03 | 0.01 | 0.02 | 0.04 | 0.06 | 0.10 | 0.00 | 0.01 | 0.03 |
| Non-operating income | 1.81 | 1.37 | 2.00 | 1.56 | 2.54 | 2.52 | 1.71 | 2.05 | 3.03 | 2.49 | 2.64 | 2.15 |
| Pre-tax profit | 7.52 | 2.98 | 7.75 | 11.78 | 8.53 | 8.32 | 3.85 | 3.72 | 7.42 | 3.69 | 8.29 | 6.95 |
| Effective tax rate % | 20.21% | 27.52% | 25.16% | 25.21% | 25.21% | 26.08% | 26.49% | 31.18% | 21.56% | 24.93% | 36.91% | 22.45% |
| Profit after tax | 6.00 | 2.16 | 5.79 | 8.80 | 6.38 | 6.14 | 2.83 | 2.56 | 5.82 | 2.78 | 5.22 | 5.39 |
| Earnings per share (Rs) | 16.79 | 6.05 | 16.21 | 24.63 | 17.86 | 17.19 | 7.92 | 7.17 | 16.29 | 7.78 | 14.61 | 15.09 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 77 | 95 | 92 | 91 | 71 | 97 | 76 | 78 | 84 | 115 | 86 | 97 |
| Operating costs | 60 | 72 | 77 | 79 | 65 | 81 | 67 | 74 | 67 | 89 | 71 | 78 |
| EBITDA | 16 | 23 | 15 | 12 | 5 | 16 | 8 | 4 | 16 | 26 | 15 | 19 |
| EBITDA margin % | 21% | 24% | 17% | 14% | 8% | 16% | 11% | 4.9% | 19% | 23% | 18% | 19% |
| Depreciation & amortisation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Finance costs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income | 3 | 3 | 4 | 5 | 6 | 4 | 6 | 7 | 6 | 8 | 10 | 10 |
| Pre-tax profit | 17 | 25 | 18 | 16 | 9 | 18 | 12 | 8 | 21 | 32 | 23 | 26 |
| Effective tax rate % | 29% | 34% | 31% | 34% | 22% | 23% | 24% | 22% | 24% | 26% | 29% | |
| Profit after tax | 12 | 16 | 12 | 10 | 7 | 14 | 9 | 6 | 16 | 24 | 16 | 19 |
| Earnings per share (Rs) | 34.71 | 45.63 | 34.85 | 28.61 | 19.96 | 37.93 | 25.33 | 18.05 | 44.20 | 67.63 | 45.85 | 53.77 |
| Paid out as dividend % | 9% | 11% | 6% | 7% | 0% | 0% | 0% | 0% | 0% | 2% | 4% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Revenue CAGR | 1% | -2% | 3% | -5% | ||
| Profit CAGR | 3% | 3% | 36% | 3% | ||
| Share price CAGR | 1% | 6% | 24% | 9% | ||
| Average return on equity | 9% | 8% | 10% | 8% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net block (property, plant) | 19 | 18 | 18 | 22 | 23 | 23 | 21 | 24 | 25 | 24 | 23 | 44 |
| Capital work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 2 | 0 |
| Investments | 1 | 5 | 39 | 45 | 28 | 25 | 33 | 46 | 41 | 50 | 52 | 46 |
| Current & other assets | 52 | 67 | 74 | 73 | 84 | 97 | 112 | 118 | 108 | 132 | 152 | 150 |
| Total assets | 72 | 89 | 131 | 140 | 136 | 144 | 168 | 190 | 174 | 206 | 229 | 241 |
| Share capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Reserves & surplus | 56 | 67 | 106 | 113 | 110 | 112 | 133 | 152 | 151 | 174 | 198 | 206 |
| Total debt | 1 | 0 | 2 | 2 | 1 | 6 | 6 | 6 | 0 | 0 | 4 | 4 |
| Other liabilities & provisions | 12 | 19 | 20 | 22 | 21 | 23 | 25 | 28 | 20 | 28 | 25 | 27 |
| Equity + liabilities | 72 | 89 | 131 | 140 | 136 | 144 | 168 | 190 | 174 | 206 | 229 | 241 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 0 | 5 | 11 | 13 | -1 | -4 | 1 | 6 | 13 | -5 | -1 | 16 |
| Investing cash flow | -0 | -3 | -10 | -13 | 3 | -2 | -0 | -6 | -3 | 1 | -0 | -18 |
| Free cash flow (after capex) | -1 | 4 | 9 | 9 | -4 | -5 | -0 | 1 | 11 | -6 | -4 | -5 |
| Financing cash flow | -0 | -0 | 0 | -3 | -1 | 4 | 0 | 0 | -6 | 0 | 3 | 0 |
| Net change in cash | -0 | 2 | 1 | -2 | 1 | -2 | 1 | 0 | 4 | -4 | 1 | -2 |
| Cash conversion (OCF / EBITDA) % | 30% | 70% | 85% | 124% | 31% | -59% | 28% | 127% | 383% | -4% | 23% | 150% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on capital employed % | 22% | 27% | 28% | 16% | 13% | 8% | 13% | 7% | 5% | 13% | 17% | 11% |
| Receivable days | 152 | 132 | 117 | 125 | 122 | 178 | 148 | 184 | 109 | 123 | 107 | 125 |
| Inventory days | 110 | 110 | 155 | 120 | 116 | 176 | 158 | 169 | 100 | 149 | 68 | 211 |
| Payable days | 66 | 80 | 75 | 87 | 91 | 129 | 108 | 81 | 34 | 130 | 46 | 103 |
| Cash cycle (days) | 196 | 162 | 197 | 157 | 146 | 225 | 198 | 272 | 176 | 142 | 129 | 233 |
| Working capital days | 194 | 179 | 164 | 161 | 171 | 241 | 178 | 222 | 221 | 183 | 140 | 203 |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoter group % | 71.51% | 71.51% | 71.51% | 71.51% | 71.51% | 71.51% | 71.51% | 71.51% | 71.51% | 71.51% | 71.51% | 71.51% |
| Foreign investors % | 0.14% | 0.14% | 0.14% | 0.23% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Retail & others % | 28.34% | 28.35% | 28.35% | 28.26% | 28.50% | 28.49% | 28.49% | 28.50% | 28.49% | 28.48% | 28.49% | 28.49% |
| Shareholder count | 3,981 | 4,005 | 4,098 | 3,831 | 3,949 | 4,054 | 4,105 | 4,213 | 4,286 | 4,208 | 4,084 | 3,873 |
Fundamentals
Market value₹ 195 Cr.
Last price₹ 545
P/E (trailing)10.3
Book value / share₹ 585
Return on capital11.0 %
Return on equity7.79 %
Dividend yield0.37 %
Face value₹ 10.0
Revenue CAGR (TTM)-5%
Profit CAGR (TTM)3%
Standalone figures.
Valuation
Market capRs 196 Cr
Enterprise valueRs 128 Cr
P/E (TTM)10.20x
Price to book0.94x
Price to sales2.03x
EV / EBITDA4.43x
EV / EBIT4.82x
EV / sales1.32x
Price to cash flow12.55x
Earnings yield9.80%
Dividend yield0.36%
P/E, 3-year average8.95x
P/B, 3-year average0.88x
P/E, 5-year average9.92x
P/B, 5-year average0.75x
Profitability
Operating margin (excl. other income)17.71%
Operating margin (incl. other income)29.59%
EBITDA margin29.85%
Pre-tax margin27.25%
Net profit margin19.87%
Net margin, latest quarter18.20%
ROE7.98%
ROCE11.13%
ROA6.97%
ROE, 3-year average10.08%
ROCE, 3-year average13.55%
ROA, 3-year average8.79%
ROE, 5-year average8.12%
ROCE, 5-year average10.79%
ROA, 5-year average7.00%
ROIC (approx.)13.34%
Tax rate29.12%
Other income / net worth4.88%
Growth
Sales growth (latest year)-25.31%
Profit growth (latest year)-32.20%
Sales CAGR, 3 years3.22%
Sales CAGR, 5 years-2.31%
Profit CAGR, 3 years36.43%
Profit CAGR, 5 years3.87%
Sales growth QoQ11.86%
Profit growth QoQ3.26%
Sales growth YoY (latest quarter)57.39%
Profit growth YoY (latest quarter)110.55%
Per share
EPS (TTM)Rs 53.77
EPS (latest year)Rs 45.85
EPS (latest quarter)Rs 15.09
EPS, 3-year averageRs 52.56
EPS, 5-year averageRs 40.21
Book value per shareRs 585.32
Sales per shareRs 270.64
Cash flow per shareRs 43.72
Dividend per share (latest year)Rs 1.99
Dividend per share, 3-year averageRs 1.75
Dividend per share, 5-year averageRs 1.75
Dividends
Dividend payout4.33%
Dividend payout, 3-year average3.28%
Dividend payout, 5-year average3.28%
Efficiency
Asset turnover0.36x
Fixed asset turnover1.95x
Inventory turnover2.09x
Inventory days175 days
Debtor days125 days
Debtors turnover2.92x
Leverage
Total debtRs 4 Cr
Cash and bankRs 73 Cr
Net debtRs -68 Cr
Debt to equity0.02x
Net debt / EBITDA-2.36x
Interest coverage156.00x
Owners' fund to total sources86.89%
Debt to assets1.80%
Cash flow
Operating cash flow (latest year)Rs 16 Cr
Investing cash flow (latest year)Rs -18 Cr
Financing cash flow (latest year)Rs 0 Cr
Net change in cash (latest year)Rs -2 Cr
Sales to cash flow5.50x
Statement figures
Net sales (TTM)Rs 97 Cr
Net sales (latest year)Rs 86 Cr
Sales (latest quarter)Rs 30 Cr
Operating profit excl. other income (latest year)Rs 15 Cr
Operating profit (latest quarter)Rs 5 Cr
Other income (TTM)Rs 10 Cr
EBITDA (TTM)Rs 29 Cr
PBDT (TTM)Rs 29 Cr
Profit before tax (TTM)Rs 26 Cr
Tax (latest year)Rs 7 Cr
Net profit (TTM)Rs 19 Cr
Net profit (latest year)Rs 16 Cr
Net profit (latest quarter)Rs 5 Cr
Depreciation (TTM)Rs 2 Cr
Depreciation (latest quarter)Rs 1 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 43 Cr
Total expenditure (latest year)Rs 71 Cr
Total income (latest year)Rs 96 Cr
Share capitalRs 4 Cr
ReservesRs 206 Cr
Shareholders' fundsRs 209 Cr
Total assetsRs 241 Cr
Net blockRs 44 Cr
Capital work in progressRs 0 Cr
InvestmentsRs 46 Cr
ReceivablesRs 29 Cr
InventoryRs 21 Cr
Other liabilitiesRs 27 Cr
Shares outstanding (crore)0.36
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 10.2 is at the 39th percentile of its own 9.4-year range
(median 10.8, low 3.5, high 28.8).
P/B 0.94 is at the 48th percentile (median 0.95).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 524506 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -5.4% | -2.8% | -2.6 pts |
| 1 month | -14.0% | -6.8% | -7.3 pts |
| 3 months | -12.6% | -7.6% | -5.0 pts |
| 3 years | +92.4% | +14.2% | +78.2 pts |
| 5 years | +36.7% | +27.9% | +8.8 pts |
Red flags
F-score 3 of 8| explain | Weak cash conversion Cash from operations was 16% of net profit over the last 3 years |
| look | Inventory outrunning sales Inventory grew 108% vs sales -25% in 2026 |
| look | Profit leans on other income Other income was 44% of pre-tax profit in 2026 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹30 Cr +57.4% vs Jun 2025.
Net profit ₹5 Cr +110.5%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Coral Laboratories Ltd?
Coral Laboratories Ltd (524506) has a market capitalisation of Rs 195 Cr. at the 2026-10-01 close.
What is the P/E ratio of Coral Laboratories Ltd?
Coral Laboratories Ltd trades at a P/E of 10.3 on trailing twelve-month profit, at the 2026-10-01 close.
What were Coral Laboratories Ltd's latest quarterly results?
In the Jun 2026 quarter, Coral Laboratories Ltd sales was Rs 30 Cr (+57.4% vs Jun 2025) and net profit was Rs 5 Cr.